Pathway construction and effectiveness evaluation of AI-enhanced influenza vaccination advocacy by primary healthcare providers for chronic obstructive pulmonary disease patients

INTERVENTION: Comparison:Usual care;Intervention:intelligent intervention;Observation group:None; CONDITION: Chronic obstructive pulmonary disease PRIMARY OUTCOME: Influenza vaccination rate among patients with COPD; SECONDARY OUTCOME: Satisfaction;Percentage of patients who received advocacy for influenza vaccine;Influenza vaccination advocacy rate among primary care providers;Influenza vaccination interval; INCLUSION CRITERIA: 1.Permanent residents under institution management who have the opportunity to receive influenza vaccine advocacy and vaccination services during the study observation period; 2.Patients with a confirmed diagnosis of COPD based on past medical records, health records, or a physician’s diagnosis; 3.Age >= 40 years; 4.Able to obtain influenza vaccination outcomes through health records, follow‐up records, or the vaccination information system; 5.The participant has provided informed consent to participate in the study.